Synthetic cannabinoid detection system and application thereof
Through lateral flow immunochromatography technology, combined with colloidal gold and fluorescent microspheres, a synthetic cannabinoid detection system was developed, which solved the rapid and accurate problems of on-site detection of synthetic cannabinoids in the existing technology, and achieved the synthesis of synthetic cannabinoids The fast and sensitive detection is suitable for on-site evidence collection by police.
Patent Information
- Application Number
- CN202411149453.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-21
- Publication Date
- 2024-11-08
AI Technical Summary
The existing technology is difficult to conduct on-site testing of synthetic cannabinoids quickly and accurately, resulting in limited on-site analysis applications and requires complex pre-processing processes and professional operations, limiting the on-site investigation of police officers.
Using lateral flow immunochromatography technology based on colloidal gold and fluorescent microspheres, a synthetic cannabinoid detection system is developed, including detection probes and immunochromatography strips, and the identification of synthetic cannabinoids through colloidal gold or fluorescent microspheres. Monoclonal antibodies are co-incubated, combining sample pads, nitrocellulose membranes and absorption pads to achieve rapid and accurate qualitative and quantitative detection.
It realizes fast, accurate and sensitive on-site testing of synthetic cannabinoids, simplifies the testing process, reduces the testing cost and time, and is suitable for on-site evidence collection by police. It can complete the testing within 15 minutes, with a detection limit of 5ng/mL. .
Smart Images

Figure CN118914543A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and in particular relates to a detection system for synthetic cannabinoids and an application thereof. Background Art
[0002] Synthetic cannabinoids (SCs) are a class of artificially synthesized cannabinoid receptor agonists, and have become the largest and most diverse class of new psychoactive substances. SCs have a strong hallucinogenic effect on the human body, accompanied by side effects such as mental disorder, cardiotoxicity, and epilepsy, which seriously threaten human health, economic development, and social stability. At present, the detection methods of synthetic cannabinoids mainly include high-performance liquid chromatography-mass spectrometry, gas chromatography-mass spectrometry, surface-enhanced Raman spectroscopy, electrochemical methods, etc., and large-scale equipment is mostly used to detect synthetic cannabis. Most of these detection technologies rely on laboratory environments, and the process is cumbersome and time-consuming, which seriously limits their on-site analysis applications, is time-consuming and labor-intensive, and requires complex pre-treatment processes and professional personnel to operate, which is not conducive to the on-site investigation of the police. Therefore, it is of great significance to develop a fast, accurate, and sensitive on-site detection method for SCs as an efficient evidence collection tool for drug crimes.
[0003] Lateral flow immunochromatography (LFIA) is a rapid analytical method that combines chromatography with immunoassay technology. It has the advantages of high stability, rapidity, portability, simplicity and user-friendliness. It has been widely used in the qualitative and semi-quantitative detection of target analytes and is currently the most commonly used point-of-care testing (POCT) platform. Colloidal gold is a negatively charged spherical nanoparticle that is simple to synthesize and stable in nature. It can be coupled to antibodies through non-covalent interactions. During the immunochromatography process, it aggregates on the T and C lines to produce a bright red color, forming a colorimetric signal visible to the naked eye. At present, LFIA based on colloidal gold has been successfully applied to many fields such as disease diagnosis, environmental monitoring and food quality testing.
[0004] Fluorescent microspheres are a special type of functionalized microspheres, which are polymers that are labeled with fluorescent substances and can produce fluorescence under certain excitations. The particle size is usually in the nanometer to micrometer range. Currently, fluorescent polymers loaded with different fluorescent substances have been developed, such as polymer microspheres doped with rare earth elements, organic dyes, quantum dots, etc. Fluorescent microspheres have been widely used in immunochromatography technology because of their stable morphological structure, good monodispersity and high luminescence efficiency. Summary of the invention
[0005] Purpose of the invention: In order to solve the above technical problems, the present invention aims to provide a detection system for synthetic cannabinoids, which can quickly and efficiently complete the qualitative and quantitative detection of indazole amide synthetic cannabinoids.
[0006] The present invention also provides a preparation method and application of a synthetic cannabinoid detection system.
[0007] Technical solution: In order to achieve the above-mentioned purpose, the present invention provides a detection system for synthetic cannabinoids, which includes a probe for detecting synthetic cannabinoids and an immunochromatographic test strip. The probe is a detection probe obtained by co-incubating a colloidal gold solution or a fluorescent microsphere solution with a monoclonal antibody that recognizes synthetic cannabinoids. The detection line of the immunochromatographic test strip is sprayed with a synthetic cannabinoid-coated antigen, and the quality control line is sprayed with a secondary antibody.
[0008] Furthermore, the synthetic cannabinoid is any one of ADB-BUTINACA (N-(1-carbamoyl-2,2-dimethylpropyl)-1-butylindazole-3-carboxamide), ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutane-2-yl)-1-(4-penten-1-yl)-1H-indazole-3-carboxamide) or 4CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide).
[0009] Furthermore, the concentration of the colloidal gold solution is 50-100 μg / mL, the concentration of the fluorescent microsphere solution is 1-10 mg / mL, and the concentration of the probe is 1-5 mg / mL.
[0010] Furthermore, the sequence of the monoclonal antibody for recognizing synthetic cannabinoids is shown in SEQ ID NO.1, the concentration of the monoclonal antibody is 1-3 mg / mL, and the incubation time is 4-6 h.
[0011] Furthermore, the structure of the immunochromatographic test strip is as follows: it comprises a sample pad (1), a nitrocellulose membrane (2), an absorption pad (5), and a polyvinyl chloride plate (6), and a detection line (3) and a quality control line (4) are arranged on the surface of the nitrocellulose membrane (2).
[0012] Preferably, the structure of the immunochromatographic test strip is as follows: a nitrocellulose membrane (2) is adhered to a back substrate of a polyvinyl chloride plate (6), a sample pad (1) and an absorption pad (5) are arranged on both sides of the back substrate of the polyvinyl chloride plate (6), the sample pad (1) and the absorption pad (5) overlap the nitrocellulose membrane (2) by 2-4 mm respectively, and a detection line (3) and a quality control line (4) are arranged on the surface of the nitrocellulose membrane (2).
[0013] Furthermore, the concentration of the synthetic cannabinoid coated antigen is 0.8-1 mg / mL, and the coating volume is 1-2 μL / cm; the concentration of the secondary antibody is 0.8-1.2 mg / mL, and the coating volume is 1-2 μL / cm.
[0014] Application of the synthetic cannabinoid detection system of the present invention in detecting synthetic cannabinoids.
[0015] Application of the synthetic cannabinoid detection system of the present invention in detecting indoleamide synthetic cannabinoids.
[0016] Furthermore, the application of the detection of indoleamide synthetic cannabinoids comprises the following steps:
[0017] (1) adding the detection probe to the sample to be tested, mixing evenly, and letting it stand to obtain an immune complex formed by the target and the detection probe;
[0018] (2) adding the immune complex obtained in step (1) to the sample pad of the test strip, and the sample liquid moves to the absorption pad under the action of capillary force, and the detection probe that is not bound to the target and the coated antigen on the detection line perform specific antigen-antibody recognition, so that the colloidal gold / fluorescent microspheres are gathered on the detection line, and the excess probes are gathered on the quality control line; using Color Picker software to analyze the RGB value of the colorimetric test paper T line, and using ImageJ software to analyze the gray value of the fluorescent test paper T line, respectively, and comparing them with the corresponding standard curves, so as to achieve quantitative judgment of the concentration of indazole amide synthetic cannabinoids in the sample to be tested.
[0019] Furthermore, in the step (1), the concentration of the sample to be tested is greater than or equal to 5 ng / mL, and the standing time is 5-20 min.
[0020] Preferably, the method for preparing the immunochromatographic test strip comprises the following steps:
[0021] (1) Cut the absorbent paper into absorbent pads with a width of 20-30 mm;
[0022] (2) preparing an indazole amide synthetic cannabinoid-coated antigen into a spray solution, and spraying it on a nitrocellulose membrane to form a detection line;
[0023] (3) preparing the secondary antibody into a spray solution and spraying it on the nitrocellulose membrane to form a quality control line;
[0024] (4) cutting the polyester film into a width of 20-30 mm, soaking it in a phosphate buffered saline solution containing 3-5% sucrose, 0.05-2% Triton-100, 0.05-0.1 mol / L tris(hydroxymethyl)aminomethane hydrochloride) for 2-4 h, and drying it at 35-42° C. for 1-3 h to obtain a sample pad;
[0025] (5) The nitrocellulose membrane is adhered to a polyvinyl chloride backing substrate, and then a sample pad and an absorption pad are adhered in sequence from one side of the polyvinyl chloride backing substrate to the other side, with the sample pad and the absorption pad overlapping the nitrocellulose membrane by 2-4 mm respectively.
[0026] The present invention provides two kinds of immunochromatographic test strips, colorimetric and fluorescent, for on-site detection of synthetic cannabinoids. The present invention adopts a sample pad, a nitrocellulose membrane, an absorption pad, and a polyvinyl chloride backing substrate to form an immunochromatographic test strip, and the sample pad, the nitrocellulose membrane, and the absorption pad are sequentially pasted on the polyvinyl chloride backing substrate, overlapping at adjacent locations, and the nitrocellulose membrane is respectively provided with a detection line and a quality control line, and the detection line is sprayed with an indazole amide synthetic cannabinoid antigen coated with bovine serum albumin, and the quality control line is sprayed with a secondary antibody. During the detection process, the sample to be tested is co-incubated with the detection probe, the target is combined with the detection probe to form an immune complex, the recognition sites on the detection probe are reduced, the combination of the detection probe with the coated antigen on the detection line is reduced, the colloidal gold / fluorescent microspheres gathered on the detection line are less, resulting in a weak colorimetric / fluorescent signal generated by the detection line, and the excess probe is combined with the secondary antibody on the quality control line, and the colloidal gold / fluorescent microspheres are gathered on the quality control line to develop color / fluorescence.
[0027] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages:
[0028] (1) The present invention provides for the first time two immunochromatographic test strips, colorimetric and fluorescent, for rapid on-site detection of indazole amide synthetic cannabinoids. The test strips are simple to assemble and easy to use, and can quickly and efficiently complete the qualitative and quantitative detection of indazole amide synthetic cannabinoids. The test strips greatly save detection time and cost, and are generally applicable to indazole amide synthetic cannabinoids.
[0029] (2) The colloidal gold-based colorimetric test paper of the present invention can read the test results with the naked eye, and the detection limit of the colorimetric test paper is 20 ng / mL. When the fluorescent test paper based on fluorescent microspheres is used in conjunction with a portable ultraviolet flashlight, it can further improve the detection sensitivity on the basis of the colorimetric test paper, which is more conducive to the police to accurately judge whether drug use has occurred. The lowest detectable concentration of indazole amide synthetic cannabinoids of the fluorescent test paper of the present invention is 5 ng / ml, and all tests can be completed within 15 minutes.
[0030] (3) The present invention has high sensitivity in detecting synthetic cannabinoids, is easy to use, and has a simple and fast process with reliable results. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 Schematic diagram of the lateral flow chromatography test strip of the present invention, wherein 1 is a sample pad, 2 is a nitrocellulose membrane, 3 is a detection line, 4 is a quality control line, 5 is an absorption pad, and 6 is a polyvinyl chloride plate;
[0032] Figure 2 is a transmission electron microscopy image of the AuNPs of the present invention;
[0033] Figure 3is a transmission electron microscope image of the fluorescent microspheres of the present invention;
[0034] Figure 4 is the UV-visible absorption spectrum of AuNPs;
[0035] Figure 5 The fluorescence spectrum of the fluorescent microspheres and the pictures under UV flashlight irradiation;
[0036] Figure 6 The colorimetric immunochromatographic test strip based on AuNPs was used to detect the indazole amide synthetic cannabinoid ADB-BUTINACA, and the visual detection result was 20 ng / mL;
[0037] Figure 7 The colorimetric detection results of the fluorescent immunochromatographic test strip based on fluorescent microspheres for the detection of the indazole amide synthetic cannabinoid ADB-BUTINACA were visualized at 5 ng / mL;
[0038] Figure 8 It is a standard curve diagram based on AuNPs detection;
[0039] Fig. 9 This is a standard curve diagram based on fluorescent microsphere detection;
[0040] Fig.10 Optimization of (A) T-line ADB-BSA spraying concentration, (B) probe addition volume, and (C) sample addition volume in TRF-LFIA; optimization of (D) T-line ADB-BSA spraying concentration, (E) probe addition volume, and (F) sample addition volume in CM-LFIA. DETAILED DESCRIPTION
[0041] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.
[0042] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources. Experimental methods without specific conditions specified in the examples are usually carried out under conventional conditions or under conditions recommended by the manufacturer.
[0043] The abbreviations of the technical terms in the present invention are as follows:
[0044] LFIA: Lateral flow immunochromatography;
[0045] AuNPs: gold nanoparticles;
[0046] ADB-BUTINACA: N-(1-carbamoyl-2,2-dimethylpropyl)-1-butylindazole-3-carboxamide;
[0047] SCs: synthetic cannabinoids;
[0048] POCT: point-of-care testing;
[0049] 4CN-CUMYL-BUTINACA: 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide);
[0050] 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide / N-hydroxysuccinimide in phosphate buffer: Weigh 10 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and 10 mg of N-hydroxysuccinimide and dissolve them in 1 mL of phosphate buffer;
[0051] Absorbent paper: manufacturer BLS, item number XSZ301244; polyester membrane: manufacturer: BLS, item number: 6613; nitrocellulose membrane: manufacturer: sartorius, item number: CN95; polyvinyl chloride flat plate: manufacturer: BLS, item number DB630;
[0052] Secondary antibody (AffiniPure TM Mouse Anti-Goat IgG (H+L): manufacturer Jackson ImmunoResearch, catalog number 205-005-018;
[0053] Samples ADB-BUTINACA (N-(1-carbamoyl-2,2-dimethylpropyl)-1-butylindazole-3-carboxamide), ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-penten-1-yl)-1H-indazole-3-carboxamide) and 4CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide) have been reported by Liu Shengfeng [1]. , Zhang Lan, Liu Shucheng, et al. Study on the Phase I metabolic rules of four amide synthetic cannabinoids in human liver microsomes [J]. Journal of China Pharmaceutical University, 2022, 53(05): 577-590. [2] Jie Zhaowei, Zhang Wenfang, Wang Jifen, et al. Metabolomics analysis of a new synthetic cannabinoid ADB-BUTINACA in zebrafish at different time periods [J]. Journal of Analysis and Testing, 2023, 42(05): 568-576. According to public reports, the experimental samples of the present invention were all taken from the National Narcotics Laboratory and filed with the Public Security Bureau;
[0054] Monoclonal antibody against ADB-BUTINACA: provided by the Joint Laboratory of Key Drug Control Technology of the Office of National Narcotics Control Commission of China Pharmaceutical University, and its amino acid sequence is shown in SEQ ID NO.1: ENVLTQSPAIISASPGEKVTMTCSASSSVSYMHWYQQRSSTSPKLWIYDTSKLASGVPGRFSGSGSGNSYSLTISSMEAEDVATYYCFQGSGYPLTFGSGTKLEIKQVQLQQSGPELVKPGASVKMSCKASGYSFTSYYIHWVKQRPGQGLEWIGWIYPGDGSTKYNEKFKGKTTLTADKSSSTAYMLLSSLTSEDSAIYFCVGYYRYDRYHFDYWGQGTTLTVSS, directly synthesized by a biological company;
[0055] Indazole amide synthetic cannabinoid ADB-BUTINACA coated antigen (preparation method refers to Chinese patent CN118063385A, coating antigen BSA-H08), the concentration is 0.8 mg / mL.
[0056] Example 1
[0057] (1) Preparation of AuNPs:
[0058] Under magnetic stirring, heat 100mL of 0.3mM chloroauric acid solution to 100℃, and add 4mL of sodium citrate (1%) reducing solution. The color of the reaction system turns wine red within 1-2min. When the color stabilizes, continue the reaction for 10min to obtain AuNPs solution with a concentration of 50μg / mL. Cover the mouth of the reaction bottle with aluminum foil and cool to room temperature. Place at 4℃ for later use. Figure 2 As shown in the figure, it is a transmission electron microscopy image of AuNPs, which shows that the synthesized AuNPs are uniformly dispersed spherical particles with no obvious aggregation phenomenon and a particle size of 18-20nm; Figure 4 As shown, it is the UV-visible absorption spectrum of AuNPs, and its surface plasmon resonance absorption peak is 521nm.
[0059] (2) Detection probe labeled with AuNPs:
[0060] Take 1 mg of anti-ADB-BUTINACA monoclonal antibody and add 1 mL of phosphate buffered saline to prepare an anti-ADB-BUTINACA monoclonal antibody solution with a concentration of 1 mg / mL for use.
[0061] Preparation of AuNPs-labeled detection probe for recognizing ADB-BUTINACA (i.e., colloidal gold-labeled detection probe): 1 mL of the 50 μg / mL AuNPs solution prepared in step (1) was taken, the pH was adjusted to 8 with 0.1 M potassium carbonate, 10 μL of phosphate buffered saline solution containing 10 μg of anti-ADB-BUTINACA monoclonal antibody was added, and incubated for 1 h, then rotated and mixed at room temperature for 1 h, and then 100 μL of 10% bovine serum albumin solution was added to block unreacted sites, and the mixture was centrifuged at 13000 rpm for 10 min. The resulting 1 mg precipitate was redispersed in 1 mL of phosphate buffered saline solution containing 10% sucrose and 1% serum albumin to obtain an AuNPs-labeled detection probe with a concentration of 1 mg / mL, which was stored at 4°C for future use.
[0062] (3) Preparation of immunochromatographic test strips:
[0063] The LFIA test strip consists of three parts: sample pad, nitrocellulose membrane and absorption pad. The absorbent paper is cut into a 20 mm wide absorption pad, which does not need further treatment. The polyester film is cut into a 20 mm wide absorption pad and soaked in 3% sucrose, 0.05% Triton-100, 0.05 mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH 8.0), phosphate buffered saline (pH 7.4) for 2 hours, and then dried at 37°C for 1 hour to obtain the sample pad. Figure 1 As shown, the nitrocellulose membrane 2 is pasted to the middle position of the back substrate of the polyvinyl chloride plate 6. The two ends of the back substrate of the polyvinyl chloride plate 6 are provided with a sample pad 1 at one end and an absorption pad 5 at the other end. One end of the sample pad 1 and the absorption pad 5 are pasted on the back substrate of the polyvinyl chloride plate 6, and the other end is pasted on the nitrocellulose membrane, overlapping the nitrocellulose membrane 2 by 2 mm respectively. A detection line 3 and a quality control line 4 are also provided on the surface of the nitrocellulose membrane 2, wherein the detection line 3 is provided close to the sample pad 1, and the quality control line 4 is provided close to the absorption pad 5. The indazole amide synthetic cannabinoid ADB-BUTINACA coated antigen is configured into a 0.8 mg / mL spray solution, and is sprayed onto the nitrocellulose membrane at a coating amount of 1 μL / cm to form a detection line 3. The secondary antibody is configured into a spray solution with a concentration of 1.0 mg / mL, and is sprayed onto the nitrocellulose membrane at a coating amount of 1 μL / cm to form a quality control line 4, which is 4 mm away from the detection line 3 and 6 mm away from the end of the nitrocellulose membrane 2.
[0064] (4) Detection method of immunochromatographic test strip: Take 60 μL of the sample to be tested (ADB-BUTINACA, concentration is 0-1000 ng / mL), add 12 μL of the detection probe prepared in step (2), mix well, let stand for 10 minutes, and then drop the mixed solution onto the sample pad of the test strip prepared in step (3). The sample solution migrates to the nitrocellulose membrane under the action of capillary force. The detection probe that is not bound to the target and the coated antigen on the detection line undergo specific antigen-antibody recognition, and the colloidal gold is aggregated on the detection line, and the excess probe is aggregated on the quality control line. After 10 minutes, the RGB value of the colorimetric test paper detection line (T line) is determined using the Color Picker software, and compared with the standard curve to perform quantitative analysis of the target concentration in the sample to be tested. Figure 6 As shown in the figure, the color development result of the indazole amide synthetic cannabinoid ADB-BUTINACA detected by the colorimetric immunochromatographic test strip based on colloidal gold, for samples with a concentration greater than or equal to 20ng / mL, the color development of the test strip test line after the test is significantly different from the negative, and the detection limit is 20ng / mL; for samples with a concentration less than 20ng / mL, the color development of the test strip test line after the test is not significantly different from the negative. Figure 8 As shown, the standard curve of the detection of indazole amide synthetic cannabinoid ADB-BUTINACA by the colorimetric immunochromatographic test strip based on colloidal gold shows that the detection platform has good linearity in the detection of ADB-BUTINACA, with a linear range of 1-1000 ng / mL and R 2 =0.9932.
[0065] Example 2
[0066] (1) Detection probes labeled with fluorescent microspheres:
[0067] 1 mg of anti-ADB-BUTINACA monoclonal antibody (same as in Example 1) was added to 1 mL of phosphate buffered saline to prepare an anti-ADB-BUTINACA monoclonal antibody solution with a concentration of 1 mg / mL for later use.
[0068] Preparation of fluorescent microsphere-labeled detection probes for recognizing ADB-BUTINACA:
[0069] S1. Preparation of fluorescent microspheres: 1 mL of styrene monomer (Shanghai MacLean Biochemical Technology Co., Ltd., catalog number: S817904, CAS number: 100-42-5), 11 mL of 3% potassium persulfate aqueous solution, and 16 mL of anhydrous ethanol were mixed at 1200 rpm, and 1 mL of rare earth complex (Shanghai MacLean Biochemical Technology Co., Ltd., catalog number: E808866, CAS number: 1308-96-9) was added. 2 Under protection, heat to 75°C and react for 8 hours to obtain fluorescent microsphere particles.
[0070] S2. Prepare the fluorescent microspheres prepared in S1 into a solution with a concentration of 10 mg / mL (take 100 μL of fluorescent microspheres and dilute them with phosphate buffer to obtain 10 mg / mL), as follows Figure 3 As shown in the figure, it is a transmission electron microscope image of the fluorescent microspheres, which shows that the fluorescent microspheres are uniformly dispersed spherical particles with no obvious aggregation phenomenon, and the particle size is 200-210nm. Figure 5 The figure shows the fluorescence spectrum of the fluorescent microspheres. Under the excitation of 365nm, there is an obvious emission peak at 615nm, and obvious red fluorescence is presented under ultraviolet flashlight irradiation. Take 40μL of 10mg / mL fluorescent microsphere solution, add 960μL of phosphate buffer containing 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide / N-hydroxysuccinimide (concentration of 10mg / mL), react for 2h in the dark, then add 40μL of phosphate buffer solution containing 20μg anti-ADB-BUTINACA monoclonal antibody for co-incubation, stir the mixed solution in the dark for 4h at room temperature, then add 100μL of 10% bovine serum albumin solution to block the unreacted sites, centrifuge at 13000rpm for 10min, and obtain the fluorescent microsphere labeled detection probe with a concentration of 1mg / mL. 1 mg of the obtained precipitate was added to 1 mL of phosphate buffered saline solution containing 10% sucrose and 1% serum albumin and stored at 4°C for later use to obtain the fluorescent microsphere-labeled detection probe with a concentration of 1 mg / mL.
[0071] (2) Preparation of immunochromatographic test strips:
[0072] The LFIA test strip consists of three parts: sample pad, nitrocellulose membrane and absorption pad. The absorbent paper is cut into a 22mm wide absorption pad, which does not need further treatment. The polyester membrane is cut into a 25mm wide sample pad, which is soaked in 4% sucrose, 0.08% Triton-100, 0.08mol / L tris(hydroxymethyl)aminomethane hydrochloride (pH 8.0), and phosphate buffered saline for 2.5h, and then dried at 37℃ for 2h to obtain the sample pad. Figure 1As shown, the nitrocellulose membrane 2 is pasted to the middle position of the back substrate of the polyvinyl chloride plate 6. The two ends of the back substrate of the polyvinyl chloride plate 6 are provided with a sample pad 1 at one end and an absorption pad 5 at the other end. One end of the sample pad 1 and the absorption pad 5 are pasted on the back substrate of the polyvinyl chloride plate 6, and the other end is pasted on the nitrocellulose membrane, overlapping the nitrocellulose membrane 2 by 2 mm respectively. A detection line 3 and a quality control line 4 are also provided on the surface of the nitrocellulose membrane 2, wherein the detection line 3 is provided close to the sample pad 1, and the quality control line 4 is provided close to the absorption pad 5. The indazole amide synthetic cannabinoid ADB-BUTINACA coated antigen to be detected is configured into a 1.0 mg / mL spray solution, and is sprayed onto the nitrocellulose membrane at a coating amount of 1 μL / cm to form a detection line. The secondary antibody is prepared into a spray solution with a concentration of 1.0 mg / mL, and is sprayed onto the nitrocellulose membrane at a coating amount of 1 μL / cm to form a quality control line.
[0073] (3) Detection method of immunochromatographic test strip: Take 70 μL of the sample to be tested (ADB-BUTINACA, 0-500 ng / mL), add 12 μL of the detection probe prepared in step (1), mix well, let stand for 10 min, and then drip the mixed solution onto the sample pad of the test strip. The sample solution migrates to the nitrocellulose membrane under the action of capillary force. After a period of time, take a photo of the test result image under ultraviolet flashlight irradiation with a smart phone, analyze the gray value of the detection line with ImageJ software, and compare it with the standard curve to perform quantitative analysis of the target concentration in the sample to be tested. Figure 7 As shown in the figure, the color development results of the fluorescent immunochromatographic test strip based on fluorescent microspheres for detecting the indazole amide synthetic cannabinoid ADB-BUTINACA, for samples with a concentration greater than or equal to 5ng / mL, the fluorescence of the test strip detection line after detection is significantly different from the negative, and the detection limit is 5ng / mL; for samples with a concentration less than 5ng / mL, there is no significant difference in the fluorescence of the test strip detection line after detection from the negative. Compared with the colorimetric signal of colloidal gold, the sensitivity is increased by 4 times. Fig. 9 As shown in the figure, the standard curve of the fluorescent immunochromatographic test strip based on fluorescent microspheres for detecting the indazole amide synthetic cannabinoid ADB-BUTINACA shows that the detection platform has good linearity for detecting ADB-BUTINACA, with a linear range of 0.5-20 ng / mL and R 2 =0.9721.
[0074] Example 3
[0075] The colorimetric immunochromatographic test strip (CM-LFIA) prepared in Example 1 and the fluorescent immunochromatographic test strip (TRF-LFIA) prepared in Example 2 were tested and compared on the detection platform. As shown in Table 1, the results of detecting the content of the indazole amide synthetic cannabinoid ADB-BUTINACA in artificial urine using the test strip detection method in step (3) of Example 1 or Example 2 were as follows: the recoveries were 92.26-109.6% and 93.6-109.1%, respectively, and the relative standard deviations were 3.01-6.3% and 2.01-3.15%, respectively, indicating that the colorimetric and fluorescent methods are highly accurate in detecting the indazole amide synthetic cannabinoid ADB-BUTINACA in artificial urine, and the detection results are reliable.
[0076] The colorimetric signal immunochromatographic test strips based on colloidal gold are used for on-site detection of synthetic cannabinoids. The colorimetric detection signal can be read by naked eyes to achieve rapid qualitative identification of the target; while the fluorescent signal immunochromatographic test strips based on fluorescent microspheres can further improve the sensitivity of colloidal gold detection and achieve accurate quantitative identification of the target. The two test strips greatly meet the different detection needs of synthetic cannabinoids. The combination of the two can not only meet the qualitative detection needs of front-line police officers for rapid drug screening, but also achieve on-site semi-quantitative detection of drugs, providing a certain reference for the conviction of criminals.
[0077] Table 1 Results of two chromatography test strips detecting the target content in artificial urine
[0078]
[0079] Example 4
[0080] In order to obtain the best detection performance, several parameters that are critical to the immunochromatographic test strips were systematically optimized. According to the methods of Examples 1 and 2, only the parameters that need to be optimized were changed, and other conditions remained unchanged. The optimized parameters are: 1. Changing the spray concentration of ADB-BSA on the T line to explore the effect of the antigen concentration on the T line; 2. Changing the added volume of the detection probe to explore the effects of different amounts of probes on the detection results; 3. Changing the amount of the sample to be tested to explore the effect of the sample solution volume on the chromatographic test strips. Through the optimization of the above parameters, the optimal detection conditions were finally obtained. The concentration of ADB-BUTINACA standard solution was 50 ng / mL or 100 ng / mL as the positive group of TRF-LFIA and CM-LFIA, and PBS was used as the negative control. The positive group (T) was compared with the negative group (T 0 ) was used as the judgment criterion to optimize the detection parameters of the two test strips.
[0081] First, the spray concentration of the coated antigen on the T line was optimized. If the spray concentration was too low, the nanoprobe could not be captured, and no band was displayed; if the concentration was too high, the sensitivity would be reduced. The T line antigen concentration of TRF-LFIA was changed to 0.4, 0.6, 0.8, and 1.0 mg / mL, and the T line antigen concentration of CM-LFIA was changed to 0.2, 0.4, 0.8, and 1.0 mg / mL. The results are shown in Fig.10 As shown in A and D, when the antigen concentration on the T line of TRF-LFIA is 1.0 mg / mL, T 0 -T is the maximum, CM-LFIA T is 0.8mg / mL when the T line 0 Therefore, 1.0 mg / mL and 0.8 mg / mL were selected as the optimal T-line coating antigen concentrations for TRF-LFIA and CM-LFIA, respectively. Secondly, 6, 8, 10, 12, and 14 μL of Eu-CM-Ab (detection probe labeled with fluorescent microspheres) / AuNPs-Ab (detection probe labeled with AuNPs) were co-incubated with the sample to be tested. As the amount of Eu-CM-Ab increased, T 0 The -T value reached the maximum at 14 μL, but the difference with 12 μL was not obvious. Considering the cost, the probe with a volume of 12 μL was selected for subsequent experiments ( Fig.10 B); As the amount of Au NPs-Ab increases, TT 0 Similarly, the maximum value was reached at 12 μL ( Fig.10 E); Finally, the effect of the added amount of the sample to be tested on the test results was optimized. When the added sample volume of TRF-LFIA was 70 μL, T 0 -Tmax( Fig.10 C) TT of CM-LFIA when the sample volume added was 60 μL 0 maximum( Fig.10 F). Therefore, 70 μL and 60 μL were selected as the sample volumes for TRF-LFIA and CM-LFIA, respectively. Table 1 summarizes the test results of the three optimal detection parameters of TRF-LFIA and CM-LFIA. The spray concentrations of the coated antigen on the T line (detection line) were 1.0 mg / mL and 0.8 mg / mL, the volumes of the Eu-CM-Ab / AuNPs-Ab probes were 12 μL, and the volumes of the samples were 70 μL and 60 μL, respectively. Fig.10 As shown, in TRF-LFIA, (A) T-line ADB-BSA spraying concentration, (B) probe addition volume, and (C) sample addition volume are optimized; in CM-LFIA, (D) T-line ADB-BSA spraying concentration, (E) probe addition volume, and (F) sample addition volume are optimized.
Claims
1. A detection system for synthetic cannabinoids, characterized in that: The detection system comprises a probe for detecting synthetic cannabinoids and an immunochromatographic test strip, wherein the probe is a detection probe obtained by co-incubating a colloidal gold solution or a fluorescent microsphere solution with a monoclonal antibody for recognizing synthetic cannabinoids, a synthetic cannabinoid coated antigen is sprayed on a detection line of the immunochromatographic test strip, and a secondary antibody is sprayed on a quality control line.
2. The detection system for synthetic cannabinoids according to claim 1, characterized in that: The synthetic cannabinoid is any one of ADB-BUTINACA (N-(1-carbamoyl-2,2-dimethylpropyl)-1-butylindazole-3-carboxamide), ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutane-2-yl)-1-(4-penten-1-yl)-1H-indazole-3-carboxamide) or 4CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide).
3. The detection system for synthetic cannabinoids according to claim 1, characterized in that: The concentration of the colloidal gold solution is 50-100 μg / mL, the concentration of the fluorescent microsphere solution is 1-10 mg / mL, and the concentration of the probe is 1-5 mg / mL.
4. The synthetic cannabinoid detection system according to claim 1, characterized in that: The sequence of the monoclonal antibody for recognizing synthetic cannabinoids is shown in SEQ ID NO.1, the concentration of the monoclonal antibody is 1-3 mg / mL, and the incubation time is 4-6 h.
5. The detection system for synthetic cannabinoids according to claim 1, characterized in that: The structure of the immunochromatographic test strip is as follows: it comprises a sample pad (1), a nitrocellulose membrane (2), an absorption pad (5), and a polyvinyl chloride plate (6); a detection line (3) and a quality control line (4) are arranged on the surface of the nitrocellulose membrane (2).
6. The synthetic cannabinoid detection system according to claim 1, characterized in that: The concentration of the synthetic cannabinoid coated antigen is 0.8-1 mg / mL, and the coating volume is 1-2 μL / cm; the concentration of the secondary antibody is 0.8-1.2 mg / mL, and the coating volume is 1-2 μL / cm.
7. Use of the synthetic cannabinoid detection system according to claim 1 in detecting synthetic cannabinoids.
8. Use of the synthetic cannabinoid detection system according to claim 1 in detecting indoleamide synthetic cannabinoids.
9. The use according to claim 8, characterized in that: The steps include: (1) adding the detection probe described in claim 1 to the sample to be tested, mixing evenly, and letting it stand to obtain an immune complex formed by the target and the detection probe; (2) adding the immune complex obtained in step (1) to the sample pad of the test strip, and the sample liquid moves to the absorption pad under the action of capillary force, and the detection probe that is not bound to the target and the coated antigen on the detection line perform specific antigen-antibody recognition, so that the colloidal gold / fluorescent microspheres are gathered on the detection line, and the excess probes are gathered on the quality control line; using Color Picker software to analyze the RGB value of the colorimetric test paper T line, and using ImageJ software to analyze the gray value of the fluorescent test paper T line, respectively, and comparing them with the corresponding standard curves, so as to achieve quantitative judgment of the concentration of indazole amide synthetic cannabinoids in the sample to be tested.
10. The application according to claim 9, characterized in that: In the step (1), the concentration of the sample to be tested is greater than or equal to 5 ng / mL, and the standing time is 5-20 min.
Citation Information
Patent Citations
Hapten for synthesizing cannabinoid ADB-BUTINACA, monoclonal antibody of synthetic cannabinoid ADB-BUTINACA and application of monoclonal antibody
CN118063385A
Time-resolved fluorescent microsphere immunochromatographic test strip for detecting cannabidiol as well as preparation method and application of time-resolved fluorescent microsphere immunochromatographic test strip
CN115327126A
Hapten for synthesizing cannabinoid and monoclonal antibody and application thereof
CN118307464A
Time-resolved fluorescent immunochromatographic test strip and kit for detecting myo, and preparation method therefor
WO2018120855A1
Cited By
Synthetic cannabinoid monoclonal antibody and application thereof in preparation of synthetic cannabinoid and structural analogue detection kit
CN122277742A
